{"paper_id":"9ec5297e-185f-4f8d-9a75-4d5ba692b61b","body_text":"Endometriosis and ovarian cancer - what they have in common?\nDOI:\nhttps://doi.org/10.12775/JEHS.2020.10.08.026Keywords\nendometriosis, ovarian cancer, ERONsAbstract\nIntroduction and purpose:\nEndometriosis is one of the most common diseases among women in the reproductive age. Although its etiology remains not fully understood, several models of endometriosis development are taken into consideration. Many studies have been focused on hormonal and genetic alterations in endometriosis. The results of these studies allow for a thesis on common origin of endometriosis anda few types of ovarian cancer.\nThe aim of this review is to present actual knowledge about endometriosis’ development conditions and a possible association with ovarian cancer.\nMaterial and method:\nThe review concerned articles published in years 2012-2020, which were collected in the PubMed and Google Scholar. Particular attention was paid to the development of both the endometriosis and Endometriosis-Related Ovarian Neoplasms (ERONs) and their genetic disorders.\nResults:\nEndometriosis development is connected with several risk factors and also immune, hormonal and genetic alterations. Some authors postulated that malignant transformation of endometriosis may be a multi-step process powered by increasing levels of estrogen. Many studies confirmed that mutations of ARID1A and PIK3CA genes are likely to be present in the majority of cases of ovarian cancer with adjacent endometriosis.\nConclusions:\nThe awareness of clinical features and medical complications of endometriosis is spreading increasingly around the world. Many studies are focused on genetic causes of this illness. It may be supposed that we will be able to select women with endometriosis and increased risk of ovarian cancer and prevent its development.\nReferences\nKrálíčková M, Losan P, Vetvicka V. Endometriosis and cancer. Womens Health (Lond). 2014; 10(6): 591-7. doi: 10.2217/whe.14.43.\nAnglesio MS, Yong PJ. Endometriosis associated Ovarian Cancers. Clin Obstet Gynecol. 2017; 60(4): 711-727. doi: 10.1097/GRF.0000000000000320.\nGaravaglia E, Sigismondi C, Ferrari S, Candiani M4. The origin of endometriosis-associated ovarian cancer from uterine neoplastic lesions. Med Hypotheses. 2018 ;110 :80-82. doi: 10.1016/j.mehy.2017.11.006\nPearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies. Lancet Oncol. 2012; 13(4): 385–394. doi: 10.1016/S1470-2045(11)70404-1\nAnglesio MS,i Bashashati A, Wang YK, Senz J, Ha G, Yang W, et al. Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden. J Pathol. 2015; 236(2): 201–209. doi: 10.1002/path.4516\nMehedintu C, Plotogea MN, Ionescu S, Antonovici M. Endometriosis still a challenge. J Med Life. 2014; 7(3): 349–357\nYuan Z, Cragun J, Chambers S, Zheng W, Wang Y. Cell origin of endometriosis: contribution by the fallopian tube epithelium. Am J Clin Exp Obstet Gynecol. 2013; 1(1): 37-42 ISSN:2330-1899/AJCEOG1310002\nShafrir AL, Farland LV, Shah DK, Harris HR, Kvaskoff M, Zondervan K, et al. Risk for and consequences of endometriosis: A critical epidemiologic review. Best Pract Res Clin Obstet Gynaecol. 2018; 51:1-15. doi: 10.1016/j.bpobgyn.2018.06.001\nMori T, Ito F, Koshiba A, Kataoka H, Tanaka Y, Okimura H, et al. Aromatase as a target for treating endometriosis. J Obstet Gynaecol Res. 2018; 44(9): 1673-1681. doi: 10.1111/jog.13743.\nBasta P, Koper K, Kazmierczak W, Wisniewski M, Makarewicz A, Dutsch-Wicherek M, et al. The biological role of Treg cells in ectopic endometrium homeostasis. Histol Histopathol. 2014; 29(10):1217-33. doi: 10.14670/HH-29.1217\nRiccio LDGC, Santulli P, Marcellin L, Abrão MS, Batteux F, Chapron C. Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol. 2018; 50:39-49. doi: 10.1016/j.bpobgyn.2018.01.010\nGogacz M, Winkler I, Bojarska-Junak A, Tabarkiewicz J, Semczuk A, Rechberger T, et al. Increased percentage of Th17 cells in peritoneal fluid is associated with severity of endometriosis. J Reprod Immunol. 2016; 117:39-44. doi: 10.1016/j.jri.2016.04.289\nIzumi G, Koga K, Takamura M, Makabe T, Satake E, Takeuchi A, et al. Involvement of immune cells in the pathogenesis of endometriosis. J Obstet Gynaecol Res. 2018; 44(2):191-198. doi: 10.1111/jog.13559\nThiruchelvam U, Wingfield M, O'Farrelly C. Natural Killer Cells: Key Players in Endometriosis. Am J Reprod Immunol. 2015; 74(4):291-301. doi: 10.1111/aji.12408\nPorpora MG, Scaramuzzino S, Sangiuliano C, Piacenti I, Bonanni V, Piccioni MG et al. High prevalence of autoimmune diseases in women with endometriosis: a case-control study. Gynecol Endocrinol. 2020 Apr;36(4):356-359. doi: 10.1080/09513590.2019.1655727\nSapkota Y, Steinthorsdottir V, Morris AP, Fassbender A, Rahmioglu N, De Vivo I, et al. Meta-analysis Identifies Five Novel Loci Associated With Endometriosis Highlighting Key Genes Involved in Hormone Metabolism. Nat Commun. 2017; 24;8:15539. doi: 10.1038/ncomms15539\nGilabert-Estelles J, Braza-Boils A, Ramon LA, Zorio E, Medina P, Espana F, et al. Role of microRNAs in gynecological pathology. Curr Med Chem. 2012; 19(15) :2406-13. doi: 10.2174/092986712800269362\nMaeda D, Shih IeM. Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. Adv Anat Pathol. 2013; 20(1):45-52. doi: 10.1097/PAP.0b013e31827bc24d\nAlcázar JL, Guerriero S, Ajossa S, Parodo G, Piras B, Peiretti M, et al. Extragenital endometrial stromal sarcoma arising in endometriosis. Gynecol Obstet Invest. 2012;73(4):265-71. doi: 10.1159/000336522.\nNezhat FR, Apostol R, Nezhat C, Pejovic T. New insights in the pathophysiology of ovarian cancer and implications for screening and prevention. Am J Obstet Gynecol. 2015; 213(3):262-7. doi: 10.1016/j.ajog.2015.03.044.\nÑiguez Sevilla I, Machado Linde F, Marín Sánchez MDP, Arense JJ, Torroba A, Nieto Díaz A, et al. Prognostic importance of atypical endometriosis with architectural hyperplasia versus cytologic atypia in endometriosis-associated ovarian cancer. J Gynecol Oncol. 2019; 30(4): e63. doi: 10.3802/jgo.2019.30.e63\nMangili G, Bergamini A, Taccagni G, Gentile C,\nPanina P, Viganò P, et al. Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience. Gynecol Oncol. 2012; 126(3): 403-7. doi: 10.1016/j.ygyno.2012.05.007\nFalconer H, Sundqvist J, Xu H, Vodolazkaia A, Fassbender A, Kyama C, et al. Analysis of common variations in tumor-suppressor genes on chr1p36 among Caucasian women with endometriosis. Gynecol Oncol. 2012; 127(2): 398-402. doi: 10.1016/j.ygyno.2012.08.013\nMunksgaard PS, Blaakaer J.The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations. Gynecol Oncol. 2012 Jan;124(1):164-9. doi: 10.1016/j.ygyno.2011.10.001.\nWang S, Qiu L, Lang JH, et al. Prognostic analysis of endometrioid epithelial ovarian cancer with or without endometriosis: a 12-year cohort study of Chinese patients. Am J Obstet Gynecol 2013 ;209: 241.e1-9 doi: 10.1016/j.ajog.2013.05.032\nVercellini P, Viganò P, Buggio L, Makieva S, Scarfone G, Cribiù FM, et al. Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated? Best Pract Res Clin Obstet Gynaecol. 2018; 51:151-168. doi: 10.1016/j.bpobgyn.2018.01.017\nWang C, Liang Z, Liu X, Zhang Q, Li S. The Association between Endometriosis, Tubal Ligation, Hysterectomy and Epithelial Ovarian Cancer: Meta-Analyses.Int J Environ Res Public Health. 2016; 14;13(11)\nKvaskoff M, Horne AW, Missmer SA. Informing women with endometriosis about ovarian cancer risk. Lancet. 2017 Dec 2;390(10111):2433-2434. doi: 10.1016/S0140-6736(17)33049-0.\nDownloads\nPublished\nHow to Cite\nIssue\nSection\nLicense\nThe periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0\nStats\nNumber of views and downloads: 1009\nNumber of citations: 0","source_license":"CC0","license_restricted":false}